OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-based design, synthesis, and biological evaluation of novel piperine–resveratrol hybrids as antiproliferative agents targeting SIRT-2
Ahmed H. Tantawy, Xiang‐Gao Meng, Adel A. Marzouk, et al.
RSC Advances (2021) Vol. 11, Iss. 41, pp. 25738-25751
Open Access | Times Cited: 13
Ahmed H. Tantawy, Xiang‐Gao Meng, Adel A. Marzouk, et al.
RSC Advances (2021) Vol. 11, Iss. 41, pp. 25738-25751
Open Access | Times Cited: 13
Showing 13 citing articles:
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 41
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 41
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access | Times Cited: 1
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access | Times Cited: 1
Resveratrol-like Compounds as SIRT1 Activators
Lidia Ciccone, Eugenia Piragine, Simone Brogi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15105-15105
Open Access | Times Cited: 33
Lidia Ciccone, Eugenia Piragine, Simone Brogi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15105-15105
Open Access | Times Cited: 33
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 30
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 30
Piperine: an emerging biofactor with anticancer efficacy and therapeutic potential
Hesti Lina Wiraswati, Ilma Fauziah Ma’ruf, Javad Sharifi‐Rad, et al.
BioFactors (2024)
Closed Access | Times Cited: 6
Hesti Lina Wiraswati, Ilma Fauziah Ma’ruf, Javad Sharifi‐Rad, et al.
BioFactors (2024)
Closed Access | Times Cited: 6
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy
Selen Gozde Kaya, Gökçen Eren
Bioorganic Chemistry (2023) Vol. 143, pp. 107038-107038
Closed Access | Times Cited: 11
Selen Gozde Kaya, Gökçen Eren
Bioorganic Chemistry (2023) Vol. 143, pp. 107038-107038
Closed Access | Times Cited: 11
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 601-601
Open Access | Times Cited: 4
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 601-601
Open Access | Times Cited: 4
Discovery of piperine derivatives as inhibitors of human dihydroorotate dehydrogenase to induce ferroptosis in cancer cells
Jianfei Zhang, Li-Hong Hong, Shiying Fan, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107594-107594
Closed Access | Times Cited: 3
Jianfei Zhang, Li-Hong Hong, Shiying Fan, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107594-107594
Closed Access | Times Cited: 3
Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E
Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Sirtuin insights: bridging the gap between cellular processes and therapeutic applications
Shagufta Kamal, Sharon Babar, Waqas Ali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9315-9344
Closed Access | Times Cited: 2
Shagufta Kamal, Sharon Babar, Waqas Ali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9315-9344
Closed Access | Times Cited: 2
2‐(Methyl(phenyl)amino)‐N‐(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition
Selen Gozde Kaya, Gökçen Eren, Alberto Massarotti, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 1
Selen Gozde Kaya, Gökçen Eren, Alberto Massarotti, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 1
In silico approach reveals N -(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits
Mahmut Gozelle, Filiz Bakar‐Ates, Alberto Massarotti, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-12
Closed Access | Times Cited: 3
Mahmut Gozelle, Filiz Bakar‐Ates, Alberto Massarotti, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-12
Closed Access | Times Cited: 3
